Koch Vitali, Biener Moritz, Müller-Hennessen Matthias, Vafaie Mershad, Staudacher Ingo, Katus Hugo A, Giannitsis Evangelos
Department of Internal Medicine III, Cardiology, Angiology and Pulmonology, Heidelberg University Hospital, Germany.
Eur Heart J Acute Cardiovasc Care. 2021 Jun 30;10(5):559–566. doi: 10.1177/2048872620907322. Epub 2020 Mar 18.
D-dimer is elevated in a variety of conditions. The purpose of this study was to assess the positive predictive value of D-dimer to rule in patients with confirmed pulmonary embolism, deep vein thrombosis, acute aortic dissection or thrombosis of the upper extremity in comparison to patients with elevated D-dimer for other reasons.
We studied 1334 patients presenting to the emergency department with pulmonary embolism (=193), deep vein thrombosis (=73), acute aortic dissection (=22), thrombosis of the upper extremity (=8) and 1038 controls. The positive predictive value was increased with higher D-dimer concentrations improving the ability to identify diseases with high thrombus burden. Patients with venous thromboembolism, acute aortic dissection and thrombosis of the upper extremity showed a maximum positive predictive value of 85.2% at a D-dimer level of 7.8 mg/L (95% confidence interval (CI) 78.1 to 90.4). The maximum positive predictive value was lower in cancer patients with venous thromboembolism, acute aortic dissection and thrombosis of the upper extremity, reaching 68.9% at a D-dimer level of 7.5 mg/L (95% CI 57.4 to 78.4). The positive likelihood ratio was very consistent with the positive predictive value. Using a cut-off level of 0.5 mg/L, D-dimer showed a high sensitivity of at least 93%, but a very low specificity of nearly 0%. Conversely, an optimised cut-off value of 4.6 mg/L increased specificity to 95% for the detection of life-threatening venous thromboembolism, acute aortic dissection or thrombosis of the upper extremity at the costs of moderate sensitivities (58% for pulmonary embolism, 41% for deep vein thrombosis, 65% for pulmonary embolism with co-existent deep vein thrombosis, 50% for acute aortic dissection and 13% for thrombosis of the upper extremity). Using the same cut-off in cancer patients, higher values were observed for sensitivity at a specificity level of more than 95%. The area under the curve for the discrimination of venous thromboembolism/acute aortic dissection/thrombosis of the upper extremity from controls was significantly higher in cancer versus non-cancer patients (area under the curve 0.905 in cancer patients, 95% CI 0.89 to 0.92, vs. area under the curve 0.857 in non-cancer patients, 95% CI 0.84 to 0.88; =0.0349).
D-dimers are useful not only to rule out but also to rule in venous thromboembolism and acute aortic dissection with an at least moderate discriminatory ability, both in patients with and without cancer.
D - 二聚体在多种情况下会升高。本研究的目的是评估D - 二聚体对于确诊肺栓塞、深静脉血栓形成、急性主动脉夹层或上肢血栓形成患者的阳性预测值,并与因其他原因导致D - 二聚体升高的患者进行比较。
我们研究了1334例就诊于急诊科的患者,其中包括肺栓塞患者(=193例)、深静脉血栓形成患者(=73例)、急性主动脉夹层患者(=22例)、上肢血栓形成患者(=8例)以及1038例对照者。随着D - 二聚体浓度升高,阳性预测值增加,提高了识别高血栓负荷疾病的能力。静脉血栓栓塞、急性主动脉夹层和上肢血栓形成患者在D - 二聚体水平为7.8 mg/L时,最大阳性预测值为85.2%(95%置信区间[CI] 78.1至90.4)。静脉血栓栓塞、急性主动脉夹层和上肢血栓形成的癌症患者最大阳性预测值较低,在D - 二聚体水平为7.5 mg/L时达到68.9%(95% CI 57.4至78.4)。阳性似然比与阳性预测值非常一致。使用0.5 mg/L的临界值时,D - 二聚体显示出至少93% 的高灵敏度,但特异性极低,接近0%。相反,优化后的临界值4.6 mg/L可将检测危及生命的静脉血栓栓塞、急性主动脉夹层或上肢血栓形成的特异性提高到95%,代价是灵敏度适中(肺栓塞为58%,深静脉血栓形成为41%,合并深静脉血栓形成的肺栓塞为65%,急性主动脉夹层为50%,上肢血栓形成为13%)。在癌症患者中使用相同的临界值,在特异性水平超过95% 时观察到更高的灵敏度值。区分静脉血栓栓塞/急性主动脉夹层/上肢血栓形成与对照者的曲线下面积在癌症患者中显著高于非癌症患者(癌症患者曲线下面积为0.905,95% CI 0.89至0.92,而非癌症患者曲线下面积为0.857,95% CI 0.84至0.88;P = 0.0349)。
D - 二聚体不仅有助于排除,也有助于诊断静脉血栓栓塞和急性主动脉夹层,在有癌症和无癌症的患者中均具有至少中等的鉴别能力。